Baotou Dongbao Bio-tech (300239) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

300239 Baotou Dongbao Bio-tech

Watchlist

5.19
-0.01-0.19%

Market Closed Jan 17 15:00 CST

3.08BMarket Cap33.92P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Dongbao Bio-Tech to Buy Back Shares of Up to 100 Million Yuan
MT NewswiresJan 6 02:41 ET
Further Upside For Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Shares Could Introduce Price Risks After 37% Bounce
Simply Wall StOct 8, 2024 19:11 ET
Here's What We Like About Baotou Dongbao Bio-TechLtd's (SZSE:300239) Upcoming Dividend
Simply Wall StMay 27, 2024 19:19 ET
Fewer Investors Than Expected Jumping On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)
Simply Wall StMay 6, 2024 19:42 ET
Do Its Financials Have Any Role To Play In Driving Baotou Dongbao Bio-Tech Co.,Ltd's (SZSE:300239) Stock Up Recently?
Simply Wall StFeb 28, 2024 18:01 ET
Not Many Are Piling Into Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Stock Yet As It Plummets 30%
Simply Wall StFeb 2, 2024 18:43 ET

Comments

Moomoo AI

Feb 2, 2024 18:15

Despite recent earnings growth, the company's P/E ratio is lower than the market, indicating shareholders may think the company has peaked. The company's three-year earnings trends aren't impacting its P/E as anticipated, hinting at potential unseen earnings threats.

Not Many Are Piling Into Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Stock Yet As It Plummets 30%

Moomoo AI

Nov 1, 2023 19:14

Despite Baotou Dongbao Bio-Tech's slightly low ROE, the company's net income growth and inferred efficient management stand out. Although the ROE is lower, significant future earnings growth is anticipated given the high reinvestment rate.